Resolve Biosciences
Axel Heinemann has a long and varied work experience. Axel started in 1993 as a Senior Partner at the Boston Consulting Group (BCG). In 2007, they founded and became Managing Director of MasterMind Transactions & Investment GmbH. Axel also founded and became Managing Director of MasterMind Advisory Services GmbH in 2008. In 2012, they founded GetSpeed Performance. In 2014, they became a Shareholder of Nürburgring 1927 GmbH & Co. KG. In 2016, they became a Shareholder and Managing Director of EnergyBus Operations GmbH. In 2020, they founded and became Managing Director of Resolve BioSciences. Most recently in 2021, they founded and became Managing Director of the European Spatial Biology Center.
Axel Heinemann obtained their Dr. rer. nat. in Biotechnology from the University of Hohenheim between 1985 and 1990.
Resolve Biosciences
Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.